Medtronic recently enrolled its first patient in a trial for the Prevail paclitaxel-coated balloon catheter for in-stent restenosis and de novo small vessel disease. The catheters are also known ...

In recent months, Medtronic has soundly outperformed the S&P 500 index. The company's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Medtronic's interest ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous glucose monitor, following a similar approval for the pairing in Europe ...

A Kentucky woman is suing Medtronic and the FDA alleging that the devicemaker’s spinal cord stimulator made her pain worse and that the agency didn’t diligently review updates to the implant. Angela ...

The MiniMed 780G automated insulin delivery system with the Simplera Sync CGM. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose ...

Medtronic plc MDT, a leading global healthcare technology company, stands out as a compelling option. It offers a distinctive combination of defensive traits and growth opportunities driven by ...

YEAH, NOT ANOTHER LIKE TV CHANNEL. JUST SAYING. KCRA 3’S MIKE TESELLE LIVE NOW WITH A SNEAK PEEK INSIDE. YOU KNOW, WE HAVE TO CLARIFY THAT MIKE. YEAH, WE’RE CHANNEL THREE. THIS IS CHANNEL 24 ...

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation in the cardiovascular, neuromodulation, and diabetes care segments ...

Medtronic’s MiniMed 780G with Simplera Sync sensor. Credit: Medtronic plc/PRNewswire. The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync ...